Prof. Derval Diana

Prof. Derval Diana

Chair of the Board of Directors

Better Immune System Foundation
Keizersgracht 62, Amsterdam, Amsterdam, Netherlands, 1015CS

plus Speciality



Diana Derval is President and Research Director of DervalResearch, international market research firm specializing in human perception and behavior, and Chair of the Board of Directors of the Better Immune System Foundation. Inventor of the Hormonal Quotient® (HQ), member of the Society for Behavioral Neuroendocrinology, and author of the books “Hormones, Talent, and Career” and “The Right Sensory Mix”-finalist of the Berry-American Marketing Association Prize for Best Marketing Book of 2011- Diana turns fascinating neuroscientific breakthroughs into powerful business frameworks to identify, understand, and predict human traits, motivations, and behavior. She has accelerated the development of Fortune 500 firms including TomTom, Sofitel, Philips, Sara Lee, and LVMH. Diana Derval teaches Sensory Science and Innovation at ESSEC Paris-Singapore Business School, and at the MBA in Health Management of the University Leonard de Vinci in Paris. Over 10,000 professionals enjoyed her inspirational lectures and workshops from Chicago to Shanghai.

Academic positions:

- Adjunct Professor in Sensory Science and Neuromarketing, MBA Health, Leonard de Vinci University, Paris. - Senior Lecturer in Innovation, ESSEC Paris-Singapore Business School, Paris.

Research interests:

- Hormones, brain, and behavior - Immune system - Sensory perception - Food-related diseases

Any other information:

The mission of the Better Immune System Foundation, chaired by Diana Derval, is to conduct research, information and prevention programs for a Better Immune System. Current clinical research investigates the link between taste perception and diabetes.

What I think of the idea behind WebmedCentral and WebmedCentral plus:

Papers presenting groundbreaking findings that are not in the mainstream direction can have a hard time being published in peer-reviewed journals. WebMedCentral gives the opportunity to share these findings at an earlier stage while ensuring a proper filtering via a post-review process. I applaud this approach.